Annual Drug Patent Expirations for ABRAXANE Abraxane is a drug marketed by Abraxis Bioscience and is included in one NDA. It is available from one supplier. There are twelve patents…
The post New patent expiration for Abraxis Bioscience drug ABRAXANE a…
New patent expiration for Abraxis Bioscience drug ABRAXANE Read Post »
This chart shows the pharmaceutical companies with the most patents in Russian Federation. Patents must be filed in each country (or, in some cases regional patent office) where patent protection…
The post Which pharmaceutical companies have the most d…
Which pharmaceutical companies have the most drug patents in Russian Federation? Read Post »
Annual Drug Patent Expirations for ZULRESSO Zulresso is a drug marketed by Sage Therap and is included in one NDA. There are seven patents protecting this drug. Drug patent litigation…
The post New patent for Sage Therap drug ZULRESSO appeared first on…
Annual Drug Patent Expirations for SUNOSI Sunosi is a drug marketed by Jazz and is included in one NDA. It is available from one supplier. There are six patents protecting…
The post New patent for JAZZ drug SUNOSI appeared first on DrugPatentWatch – Ma…
Annual Drug Patent Expirations for UTIBRON Utibron is a drug marketed by Novartis and is included in one NDA. It is available from one supplier. There are eighteen patents protecting…
The post New patent expiration for Novartis drug UTIBRON appeared fi…
Annual Drug Patent Expirations for SEEBRI Seebri is a drug marketed by Novartis and is included in one NDA. It is available from one supplier. There are twelve patents protecting…
The post New patent expiration for Novartis drug SEEBRI appeared first o…
This chart shows the pharmaceutical companies with the most patents in Lithuania. Patents must be filed in each country (or, in some cases regional patent office) where patent protection is…
The post Which pharmaceutical companies have the most drug pa…
Which pharmaceutical companies have the most drug patents in Lithuania? Read Post »
SEEBRI (glycopyrrolate) Novartis Patent: 7,229,607 Expiration: Apr 9, 2021 See More … For more information on how DrugPatentWatch can help with your pharmaceutical business intelligence needs, contact [email protected] or visit…
The post Drug P…
Drug Patent Expirations for the Week of April 4, 2021 Read Post »
Annual Drug Patent Expirations for FINTEPLA Fintepla is a drug marketed by Zogenix Inc and is included in one NDA. It is available from one supplier. There are eight patents…
The post New patent for Zogenix Inc drug FINTEPLA appeared first on DrugPaten…
Annual Drug Patent Expirations for INGREZZA Ingrezza is a drug marketed by Neurocrine and is included in one NDA. It is available from one supplier. There are eight patents protecting…
The post New patent for Neurocrine drug INGREZZA appeared first on …
Get new actionable insights and updates from BiotechBlog
